Close

Analyst Ratings for First Wave BioPharma, Inc. (FWBI) [Neutrals]

FWBI Rating Summary

  |   Expand Research on FWBI
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: N/A
Rating Score: 0 / 10   Percentile Rank: 0%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/25/2024 H.C. Wainwright Yi Chen New Coverage Neutral
(N/A)
N/A
(N/A)
4.42
(3.12)
-29.41% Details
12/7/2021 Maxim Group Naz Rahman Downgrade Hold
(Buy)
N/A
(N/A)
1.40
(3.12)
122.86% Details